The central feature of B cell development is the regulated production of first the pre-B cell receptor and then immunoglobulin, the functional antigen receptor. The subunit composition of receptors, the amount of protein synthesized and the traffic of the receptors are subject to large and regulated changes. Through their ability to associate with individual subunits and assembly intermediates of the antigen receptors, molecular chaperones in the endoplasmic reticulum are, in large part, responsible for the regulation of synthesis and folding. We hypothesize that at least two chaperones, BiP and GRP94, act in concert to mediate efficient assembly of pre-B and B cell receptors and guide the repertoire selection of H and LCs that have undergone somatic mutation. Thus, the focus of this proposal is to determine how BiP recognizes newly synthesized receptor subunits and how GRP94, which we showed to be a different type of chaperone, recognizes its substrates and interfaces with BiP.
The specific aims are: 1) To use a new cell-free assay to map BiP binding sites in Ig variable domains, determine if they are similar in wild type and in pathologic Ig and study how BiP and GRP94 chaperone aggregation-prone Ig. 2) To test the mechanism by which Ig is relayed from BiP to GRP94 using in vivo experiments with a dominant-negative mutant of BiP and in vitro experiments with purified BiP, GRP94 and LCs. 3) To define how BiP and GRP94 associate with the three subunits of the pre-B cell receptor during its assembly and compare the assembly of the surrogate LC when paired with H chains having different VH domains. 4) To ablate expression of GRP94 via homologous recombination in order to assess its role in lymphocyte development. Because immunoglobulins share a great deal of structural homology with many other antigen receptors, co-receptors and adhesion molecules, it is highly likely that the mechanisms defined by this work will have widespread implications for other aspects of immunology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI030178-13
Application #
6782107
Study Section
Immunobiology Study Section (IMB)
Program Officer
Nasseri, M Faraz
Project Start
1990-04-01
Project End
2005-02-28
Budget Start
2003-03-03
Budget End
2005-02-28
Support Year
13
Fiscal Year
2003
Total Cost
$448,710
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ostrovsky, Olga; Eletto, Davide; Makarewich, Catherine et al. (2010) Glucose regulated protein 94 is required for muscle differentiation through its control of the autocrine production of insulin-like growth factors. Biochim Biophys Acta 1803:333-41
Biswas, Chhanda; Ostrovsky, Olga; Makarewich, Catherine A et al. (2007) The peptide-binding activity of GRP94 is regulated by calcium. Biochem J 405:233-41
Elkabetz, Yechiel; Argon, Yair; Bar-Nun, Shoshana (2005) Cysteines in CH1 underlie retention of unassembled Ig heavy chains. J Biol Chem 280:14402-12
Gidalevitz, Tali; Biswas, Chhanda; Ding, Hua et al. (2004) Identification of the N-terminal peptide binding site of glucose-regulated protein 94. J Biol Chem 279:16543-52
Goyard, Sophie; Segawa, Hiroaki; Gordon, Jennifer et al. (2003) An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol Biochem Parasitol 130:31-42
Davis, D P; Gallo, G; Vogen, S M et al. (2001) Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain. J Mol Biol 313:1021-34
Dul, J L; Davis, D P; Williamson, E K et al. (2001) Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains. J Cell Biol 152:705-16
Stevens, F J; Argon, Y (1999) Protein folding in the ER. Semin Cell Dev Biol 10:443-54
Davis, D P; Khurana, R; Meredith, S et al. (1999) Mapping the major interaction between binding protein and Ig light chains to sites within the variable domain. J Immunol 163:3842-50
Stevens, F J; Argon, Y (1999) Pathogenic light chains and the B-cell repertoire. Immunol Today 20:451-7

Showing the most recent 10 out of 14 publications